{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:13:07Z","timestamp":1793463187280,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008021","name":"Fujian University of Traditional Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20784"],"award-info":[{"award-number":["U24A20784"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473812"],"award-info":[{"award-number":["82473812"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110372","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:40:09Z","timestamp":1786491609000},"page":"110372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery of DCAF16-based PROTACs as SHP2 degraders"],"prefix":"10.1016","volume":"181","author":[{"given":"Xiaojing","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenshuo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110372_bb0005","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202202078RR","article-title":"Deletion of the tyrosine phosphatase Shp2 in cervical cancer cells promotes reprogramming of glutamine metabolism","volume":"37","author":"Gao","year":"2023","journal-title":"FASEB J."},{"key":"10.1016\/j.bioorg.2026.110372_bb0010","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.2147\/OTT.S210223","article-title":"The prognostic significance of SHP2 and its binding protein Hook1 in non-small cell lung cancer","volume":"12","author":"He","year":"2019","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.bioorg.2026.110372_bb0015","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","author":"McLendon","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.110372_bb0020","doi-asserted-by":"crossref","first-page":"8816","DOI":"10.1158\/0008-5472.CAN-04-1923","article-title":"Activating mutations of the Noonan syndrome-associated SHP2\/PTPN11 gene in human solid Tumors and adult acute myelogenous Leukemia","volume":"64","author":"Bentires-Alj","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110372_bb0025","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nm.2645","article-title":"Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop","volume":"18","author":"Aceto","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2026.110372_bb0030","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.22556","article-title":"Dietary quercetin potentiates the antiproliferative effect of interferon-\u03b1 in hepatocellular carcinoma cells through activation of JAK\/STAT pathway signaling by inhibition of SHP2 phosphatase","volume":"8","author":"Igbe","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2026.110372_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166751","article-title":"Chlorogenic acid prevents osteoporosis by Shp2\/PI3K\/Akt pathway in ovariectomized rats","volume":"11","author":"Zhou","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.bioorg.2026.110372_bb0040","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/s41591-018-0023-9","article-title":"SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo","volume":"24","author":"Mainardi","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2026.110372_bb0045","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1158\/0008-5472.CAN-14-1215","article-title":"PD-1\/SHP-2 inhibits Tc1\/Th1 phenotypic responses and the activation of T cells in the tumor microenvironment","volume":"75","author":"Li","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110372_bb0050","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4049\/jimmunol.173.2.945","article-title":"SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation","volume":"173","author":"Chemnitz","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.bioorg.2026.110372_bb0055","article-title":"Design, synthesis, and evaluation of PD-L1 degraders to enhance T cell killing activity against melanoma","volume":"34","author":"Liu","year":"2023","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110372_bb0060","article-title":"PD-L1\/SHP2 dual PROTACs inhibit melanoma by enhancing T-cell killing activity","volume":"36","author":"Liu","year":"2025","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110372_bb0065","doi-asserted-by":"crossref","first-page":"7773","DOI":"10.1021\/acs.jmedchem.6b00680","article-title":"Allosteric inhibition of SHP2: identification of a potent, selective, and orally efficacious phosphatase inhibitor","volume":"59","author":"Garcia Fortanet","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110372_bb0070","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nature18621","article-title":"Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases","volume":"535","author":"Chen","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.110372_bb0075","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1038\/sj.onc.1206846","article-title":"Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling","volume":"22","author":"Yu","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2026.110372_bb0080","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.immuni.2006.10.014","article-title":"SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production","volume":"25","author":"An","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.bioorg.2026.110372_bb0085","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jphs.2020.06.002","article-title":"Phosphatase-independent functions of SHP2 and its regulation by small molecule compounds","volume":"144","author":"Guo","year":"2020","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2026.110372_bb0090","doi-asserted-by":"crossref","first-page":"8554","DOI":"10.1073\/pnas.141230798","article-title":"Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation","volume":"98","author":"Sakamoto","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2026.110372_bb0095","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41573-019-0047-y","article-title":"Targeted protein degradation: expanding the toolbox","volume":"18","author":"Schapira","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110372_bb0100","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1126\/science.aam7340","article-title":"Waste disposal-An attractive strategy for cancer therapy","volume":"355","author":"Salami","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2026.110372_bb0105","doi-asserted-by":"crossref","first-page":"7510","DOI":"10.1021\/acs.jmedchem.0c00471","article-title":"Discovery of SHP2-D26 as a first, potent, and effective PROTAC degrader of SHP2 protein","volume":"63","author":"Wang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110372_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113341","article-title":"Discovery of thalidomide-based PROTAC small molecules as the highly efficient SHP2 degraders","volume":"218","author":"Yang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110372_bb0115","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1244851","article-title":"Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells","volume":"343","author":"Kr\u00f6nke","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2026.110372_bb0120","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1039\/D2MD00347C","article-title":"Structural rationalization of GSPT1 and IKZF1 degradation by thalidomide molecular glue derivatives","volume":"14","author":"Nowak","year":"2023","journal-title":"RSC Medicinal Chemistry"},{"key":"10.1016\/j.bioorg.2026.110372_bb0125","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1152\/physiol.00001.2004","article-title":"Hydroxylation of HIF-1: oxygen sensing at the molecular level","volume":"19","author":"Semenza","year":"2004","journal-title":"Physiology"},{"key":"10.1016\/j.bioorg.2026.110372_bb0130","doi-asserted-by":"crossref","first-page":"10430","DOI":"10.1073\/pnas.190332597","article-title":"Activation of HIF1\u03b1 ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex","volume":"97","author":"Kamura","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2026.110372_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108532","article-title":"Functional genomics identify distinct and overlapping genes mediating resistance to different classes of heterobifunctional degraders of oncoproteins","volume":"34","author":"Shirasaki","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.bioorg.2026.110372_bb0140","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.chembiol.2021.04.007","article-title":"Expanding the arsenal of E3 ubiquitin ligases for proximity-induced protein degradation","volume":"28","author":"Kannt","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110372_bb0145","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1039\/D2CS00200K","article-title":"Target and tissue selectivity of PROTAC degraders","volume":"51","author":"Guenette","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioorg.2026.110372_bb0150","doi-asserted-by":"crossref","DOI":"10.15212\/AMM-2022-1001","article-title":"Drug discovery is an eternal challenge for the biomedical sciences","volume":"1","author":"Li","year":"2022","journal-title":"Acta Materia Medica"},{"key":"10.1016\/j.bioorg.2026.110372_bb0155","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.molcel.2007.06.001","article-title":"DCAFs, the missing link of the CUL4-DDB1 ubiquitin ligase","volume":"26","author":"Lee","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bioorg.2026.110372_bb0160","doi-asserted-by":"crossref","first-page":"13369","DOI":"10.1021\/acs.jmedchem.3c01209","article-title":"Unlocking DCAFs to catalyze degrader development: An arena for innovative approaches","volume":"66","author":"Miao","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110372_bb0165","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1039\/D4MD00681J","article-title":"Exploiting the DCAF16-SPIN4 interaction to identify DCAF16 ligands for PROTAC development","volume":"16","author":"Riha","year":"2025","journal-title":"RSC Medicinal Chemistry"},{"key":"10.1016\/j.bioorg.2026.110372_bb0170","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41589-019-0279-5","article-title":"Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16","volume":"15","author":"Zhang","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110372_bb0175","doi-asserted-by":"crossref","first-page":"18688","DOI":"10.1021\/jacs.2c08964","article-title":"Targeted protein degradation by electrophilic PROTACs that Stereoselectively and site-specifically engage DCAF1","volume":"144","author":"Tao","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.110372_bb0180","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1021\/jacs.1c00990","article-title":"DCAF11 supports targeted protein degradation by electrophilic proteolysis-targeting chimeras","volume":"143","author":"Zhang","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.110372_bb0185","doi-asserted-by":"crossref","first-page":"8516","DOI":"10.1038\/s41467-025-63594-w","article-title":"Mode of action of a DCAF16-recruiting targeted glue that can selectively degrade BRD9","volume":"16","author":"Hughes","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110372_bb0190","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/s41589-024-01668-4","article-title":"Template-assisted covalent modification underlies activity of covalent molecular glues","volume":"20","author":"Li","year":"2024","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110372_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117918","article-title":"Discovery of SA-8 as a potent SHP2-AUTAC degrader in cancer therapy","volume":"297","author":"Song","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110372_bb0200","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1021\/ja039025z","article-title":"Chemical genetic control of protein levels: selective in vivo targeted degradation","volume":"126","author":"Schneekloth","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.110372_bb0205","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00418-022-02086-0","article-title":"A higher dose of PEGylated gold nanoparticles reduces the accelerated blood clearance phenomenon effect and induces spleen B lymphocytes in albino mice","volume":"157","author":"Abu-Dief","year":"2022","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.110372_bb0210","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1007\/s13204-023-02770-0","article-title":"The bioreaction and immune responses of PEG-coated silica NPs and the role of the surface density coating after oral administration into mice, applied","volume":"13","author":"Abu-Dief","year":"2023","journal-title":"Nanoscience"},{"key":"10.1016\/j.bioorg.2026.110372_bb0215","doi-asserted-by":"crossref","first-page":"8822","DOI":"10.1021\/acs.jmedchem.3c00405","article-title":"Discovery of ARD-2051 as a potent and orally efficacious proteolysis targeting chimera (PROTAC) degrader of androgen receptor for the treatment of advanced prostate Cancer","volume":"66","author":"Han","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110372_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13020226","article-title":"Novel green biosynthesis of 5-fluorouracil chromium nanoparticles using Harpullia pendula extract for treatment of colorectal cancer","volume":"13","author":"Saddik","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioorg.2026.110372_bb0225","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1007\/s11164-020-04380-9","article-title":"Structural, conformational and therapeutic studies on new thiazole complexes: drug-likeness and MOE-simulation assessments","volume":"47","author":"Abu-Dief","year":"2021","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.bioorg.2026.110372_bb0230","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/s41556-018-0169-1","article-title":"RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers","volume":"20","author":"Nichols","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.110372_bb0235","series-title":"Assessing cellular target engagement by SHP2 (PTPN11) Phosphatase Inhibitors","author":"Lambert","year":"2020"},{"key":"10.1016\/j.bioorg.2026.110372_bb0240","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm2059","article-title":"How can same-gene mutations promote both cancer and developmental disorders?","volume":"8","author":"Nussinov","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioorg.2026.110372_bb0245","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cellsig.2007.10.002","article-title":"The molecular functions of Shp2 in the Ras\/mitogen-activated protein kinase (ERK1\/2) pathway","volume":"20","author":"Dance","year":"2008","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bioorg.2026.110372_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13205059","article-title":"Progress on Ras\/MAPK signaling research and targeting in blood and solid cancers","volume":"13","author":"Dillon","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2026.110372_bb0255","doi-asserted-by":"crossref","first-page":"22992","DOI":"10.1074\/jbc.M312498200","article-title":"Shp2, an SH2-containing protein-tyrosine phosphatase, positively regulates receptor tyrosine kinase Signaling by dephosphorylating and inactivating the inhibitor Sprouty*","volume":"279","author":"Hanafusa","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110372_bb0260","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1073\/pnas.91.15.7335","article-title":"Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor beta to Ras","volume":"91","author":"Bennett","year":"1994","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110372_bb0265","first-page":"1589","article-title":"Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584","volume":"7","author":"Vogel","year":"1996","journal-title":"Cell growth & differentiation : the molecular biology journal of the American association for Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110372_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12102799","article-title":"Oncogenic tyrosine phosphatases: novel therapeutic targets for melanoma treatment","volume":"12","author":"Pardella","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2026.110372_bb0275","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1038\/sj.onc.1204699","article-title":"The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase\/Akt activation by growth factors","volume":"20","author":"Wu","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2026.110372_bb0280","series-title":"Methods in Enzymology","first-page":"549","article-title":"Chapter 27 - measurement of constitutive MAPK and PI3K\/AKT Signaling activity in human Cancer cell lines","author":"Paraiso","year":"2010"},{"key":"10.1016\/j.bioorg.2026.110372_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107121","article-title":"Druggable targets of protein tyrosine phosphatase family, viz. PTP1B, SHP2, Cdc25, and LMW-PTP: current scenario on medicinal attributes, and SAR insights","volume":"144","author":"Bhavana","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110372_bb0290","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/s12964-025-02498-0","article-title":"Targeting SHP2 to reverse immune evasion and resistance to anti-PD-1 therapy in non-small cell lung cancer","volume":"23","author":"Chen","year":"2025","journal-title":"Cell Communication and Signaling"},{"key":"10.1016\/j.bioorg.2026.110372_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156731","article-title":"Celastrol enhanced CD8+T cell immunity in melanoma by targeting SHP2 and upregulating MHC-I","volume":"142","author":"Kong","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bioorg.2026.110372_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.inoche.2026.116479","article-title":"Eco-friendly synthesis of novel nanocomplexes: integrated in vitro evaluation, advanced molecular dynamics simulations, network pharmacology, and in silico ADME\/toxicity assessment","volume":"188","author":"Hosny","year":"2026","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.bioorg.2026.110372_bb0305","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molimm.2013.03.014","article-title":"Structural and functional mosaic nature of MHC class I molecules in their peptide-free form","volume":"55","author":"Kurimoto","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bioorg.2026.110372_bb0310","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/s41598-021-80999-x","article-title":"SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms","volume":"11","author":"Wang","year":"2021","journal-title":"Sci. Rep."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:08:55Z","timestamp":1791407335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826009089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":62,"alternative-id":["S0045206826009089"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110372","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of DCAF16-based PROTACs as SHP2 degraders","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110372"}}